Premium
Expression of E‐ and N‐cadherin and clinicopathology in hepatocellular carcinoma
Author(s) -
Cho Sung Bum,
Lee Kyung Hwa,
Lee Jae Hyek,
Park Sun Young,
Lee Wan Sik,
Park Chang Hwan,
Kim Hyun Soo,
Choi Sung Kyu,
Rew Jong Sun
Publication year - 2008
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/j.1440-1827.2008.02282.x
Subject(s) - cadherin , staining , immunohistochemistry , hepatocellular carcinoma , pathology , carcinoma , medicine , odds ratio , positive staining , confidence interval , biology , cell , genetics
Loss or reduced E‐cadherin expression and aberrant expression of N‐cadherin have been associated with invasiveness of human carcinoma cells and poor prognosis. The role of E‐ and N‐cadherin, however, in hepatocellular carcinoma (HCC) has not yet been elucidated. The aim of the present study was to investigate the expression pattern of E‐ and N‐cadherin in surgically resected HCC specimens according to their relationship with clinicopathological features. The expression patterns of E‐ and N‐cadherin were evaluated on immunohistochemistry in 68 specimens of HCC and adjacent non‐tumor tissue. The most different expression pattern between HCC and non‐tumor tissue was the decreased staining intensity of E‐cadherin ( n = 37, 54%) and the dot‐like discontinuous staining of N‐cadherin ( n = 35, 55%). Decreased intensity of E‐cadherin and discontinuous staining of N‐cadherin in HCC was correlated with advanced stage. The risk factors for expression patterns related to recurrence were loss of E‐cadherin expression (odds ratio (OR) = 3.6; 95% confidence interval (CI): 1.1–12.4) and discontinuous staining of N‐cadherin (OR = 1.6; 95% CI: 0.8–3.2). In conclusion, discontinuous staining of N‐cadherin and loss of E‐cadherin expression in HCC predicts a high risk of recurrence after surgical treatment.